Jiaci

29 / 80

Neuropathic Pain/Itch in Allergic Conjunctivitis
J Investig Allergol Clin Immunol 2019; Vol. 29(5): 349-356 © 2019 Esmon Publicidad
doi: 10.18176/jiaci.0320
38. Micera A, Lambiase A, Bonini S. The role of neuromediators in
ocular allergy. Curr OpinAllergy Clin Immunol. 2008;8(5):466-71.
39. Sacchetti M, Micera A, Lambiase A, Speranza S, Mantelli F,
Petrachi G, et al. Tear levels of neuropeptides increase after
specific allergen challenge in allergic conjunctivitis. Mol Vis.
2011;17:47-52.
40. Lambiase A, Bonini S, Micera A, Rama P, Bonini S, Aloe L.
Expression of nerve growth factor receptors on the ocular
surface in healthy subjects and during manifestation
of inflammatory diseases. Invest Ophthalmol Vis Sci.
1998;39(7):1272-5.
41. Bielory L. Ocular allergy and dry eye syndrome. Curr Opin
Allergy Clin Immunol. 2004;4(5):421-4.
42. Dogru M, Gunay M, Celik G, Aktas A. Evaluation of the tear
film instability in children with allergic diseases. Cutan Ocul
Toxicol. 2016;35(1):49-52.
43. Kalangara JP, Galor A, Levitt RC, Felix ER, Alegret R,
Sarantopoulos CD. Burning Eye Syndrome: Do Neuropathic
Pain Mechanisms Underlie Chronic Dry Eye? Pain Med.
2016;17(4):746-55.
44. Siebenhaar F, Magerl M, Peters EM, Hendrix S, Metz M,
Maurer M. Mast cell-driven skin inflammation is impaired
in the absence of sensory nerves. J Allergy Clin Immunol.
2008;121(4):955-61.
45. Quan L, He H. Treatment with olopatadine and naphazoline
hydrochloride reduces allergic conjunctivitis in mice through
alterations in inflammation, NGF and VEGF. Mol Med Rep.
2016;13(4):3319-25.
46. Trankner D, Hahne N, Sugino K, Hoon MA, Zuker C.
Population of sensory neurons essential for asthmatic
hyperreactivity of inflamed airways. Proc Natl Acad Sci U S A.
2014;111(31):11515-20.
47. Yun JW, Seo JA, Jeong YS, Bae IH, Jang WH, Lee J, et al.
TRPV1 antagonist can suppress the atopic dermatitis-like
symptoms by accelerating skin barrier recovery. J Dermatol
Sci. 2011;62(1):8-15.
48. Huang CC, Kim YS, Olson WP, Li F, Guo C, Luo W, et al. A
histamine-independent itch pathway is required for allergic
ocular itch. J Allergy Clin Immunol. 2016;137(4):1267-70 e6.
49. Bareille P, Murdoch RD, Denyer J, Bentley J, Smart K, Yarnall
K, et al. The effects of a TRPV1 antagonist, SB-705498, in the
treatment of seasonal allergic rhinitis. Int J Clin Pharmacol
Ther. 2013;51(7):576-84.
50. Murdoch RD, Bareille P, Denyer J, Newlands A, Bentley J, Smart
K, et al. TRPV1 inhibition does not prevent cold dry air-elicited
symptoms in non-allergic rhinitis. Int J Clin Pharmacol Ther.
2014;52(4):267-76.
51. Bernstein JA, Davis BP, Picard JK, Cooper JP, Zheng S, Levin LS.
A randomized, double-blind, parallel trial comparing capsaicin
nasal spray with placebo in subjects with a significant
component of nonallergic rhinitis. Ann Allergy Asthma
Immunol. 2011;107(2):171-8.
52. Gevorgyan A, Segboer C, Gorissen R, van Drunen CM, Fokkens
W. Capsaicin for non-allergic rhinitis. Cochrane Database Syst
Rev. 2015(7):CD010591.
53. Van Rijswijk JB, Boeke EL, Keizer JM, Mulder PG, Blom HM,
Fokkens WJ. Intranasal capsaicin reduces nasal hyperreactivity
in idiopathic rhinitis: a double-blind randomized application
regimen study. Allergy. 2003;58(8):754-61.
54. Morice AH, Faruqi S,Wright CE, Thompson R, Bland JM. Cough
hypersensitivity syndrome: a distinct clinical entity. Lung.
2011;189(1):73-9.
55. Ryan NM, Birring SS, Gibson PG. Gabapentin for refractory
chronic cough: a randomised, double-blind, placebo-
controlled trial. Lancet. 2012;380(9853):1583-9.
56. Cevikbas F, Braz JM,Wang X, Solorzano C, Sulk M, Buhl T, et al.
Synergistic antipruritic effects of gamma aminobutyric acid A
and B agonists in a mouse model of atopic dermatitis. J Allergy
Clin Immunol. 2017;140(2):454-64 e2.
57. Yosipovitch G, Bernhard JD. Clinical practice. Chronic pruritus.
N Engl J Med. 2013;368(17):1625-34.
Manuscript received June 20, 2018; accepted for
publication September 11, 2018.
Merin Elizabeth Kuruvilla
1365 Clifton Rd NE, Bldg A, 3rd Flr
Atlanta, GA-30322
USA
E-mail:
356